News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Supreme Court Throws Out Prometheus Laboratories Inc. Patent in Blood Test Dispute, Deals Blow to Biotechs



3/21/2012 7:40:24 AM

The Supreme Court has tossed out a medical patent for Prometheus Laboratories, a decision that could affect the burgeoning field of personalized medicine. The justices on Tuesday unanimously agreed that the patent held by the company -- owned by Switzerland-based Nestle -- was invalid. The patent covers a blood test that helps doctors determine the proper dosage for a drug, thiopurine, to treat autoimmune illnesses. The Minnesota-based Mayo Clinic had challenged the patent, which is keeping them from marketing its own test.

Read at BusinessWeek
Read at Chicago Tribune
Read at Washington Post
Read at New York Times
Read at Nature


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES